On the West Coast, Enumclaw, Washington residents have many health-conscious options. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk, approved since 2021. Weight Method offers a separate telehealth program: licensed Washington providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for Enumclaw starts at $199/month, including the provider evaluation, the medication, ongoing care, and home delivery.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Enumclaw is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Enumclaw, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Wegovy® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2021 for Chronic weight management. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Enumclaw residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Enumclaw's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk since 2021. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Semaglutide delivered to your Enumclaw address at $199/month. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.